中国P站

Exosomes; Cancer Therapy; Drug Delivery; Biomarkers; Neurodegenerative Diseases; Immune Regulation; Inflammatory Diseases; Cardiovascular Diseases; Tissue Regeneration; Viral Infections

Introduction

Exosomes are emerging as crucial players in the diagnosis and therapy of various cancers. Their unique ability to transport biologically active molecules, like proteins, lipids, and nucleic acids, facilitates cell-to-cell communication within the tumor microenvironment, influencing tumor growth, metastasis, and drug resistance. Understanding their role can lead to novel diagnostic biomarkers and therapeutic strategies, including exosome-based drug delivery systems [1].

Exosome-mediated intercellular communication is a significant factor in the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's. Exosomes can transfer toxic proteins, microRNAs, and other molecules between neurons and glial cells, contributing to disease pathology. Targeting exosome signaling pathways offers potential avenues for therapeutic intervention and the development of diagnostic biomarkers for early detection [2].

Exosomes play a critical role in immune regulation and the pathogenesis of inflammatory diseases. They carry diverse immune modulatory cargos that can activate or suppress immune responses, influencing processes like antigen presentation, T-cell activation, and cytokine secretion. This makes them attractive targets for developing new immunotherapies and diagnostics for autoimmune conditions and chronic inflammation [3].

Utilizing exosomes as natural nanocarriers for drug delivery systems shows immense promise in cancer therapy. Their biocompatibility, low immunogenicity, and ability to cross biological barriers make them ideal for targeted delivery of chemotherapeutics, siRNAs, or CRISPR/Cas9 components to tumor cells, minimizing off-target effects and enhancing therapeutic efficacy [4].

Exosomes play an important role in intercellular communication within the cardiovascular system, contributing to both physiological functions and pathological conditions. They facilitate the exchange of genetic material and proteins, influencing processes like angiogenesis, cardiac repair, and inflammation in diseases such as myocardial infarction, atherosclerosis, and heart failure. Their potential as biomarkers and therapeutic agents is being actively explored [5].

In stem cell-based therapies and tissue regeneration, exosomes derived from stem cells have garnered significant attention. These exosomes carry regenerative molecules that mimic many of the therapeutic effects of their parent cells, promoting cell proliferation, differentiation, and tissue repair. This characteristic positions them as a cell-free alternative for regenerative medicine, offering advantages in terms of safety and scalability [6].

Exosomes hold significant promise as potential biomarkers for the early diagnosis and prognosis of digestive system malignancies. Their cargo, reflecting the physiological and pathological state of parental cells, can be non-invasively detected in body fluids. Beyond diagnostics, exosomal components are also being explored as novel therapeutic targets, offering a refined approach to cancer treatment [7].

Intercellular communication mediated by exosomes is recognized as a key factor in the pathogenesis and progression of various liver diseases, including non-alcoholic fatty liver disease, viral hepatitis, and liver fibrosis. Exosomes transport a diverse array of molecules that modulate inflammation, apoptosis, and fibrogenesis in the liver. Understanding these mechanisms is crucial for developing new diagnostic tools and targeted therapies [8].

Plant-derived exosomes, also known as exosome-like nanoparticles, represent a new paradigm for drug delivery. These naturally occurring vesicles possess excellent biocompatibility, low toxicity, and high stability, making them suitable for encapsulating and delivering various therapeutic agents. Their ability to deliver bioactive compounds across biological barriers offers a promising and sustainable platform for developing novel biopharmaceuticals [9].

Exosomes are key players in viral infections, influencing every stage from pathogenesis to potential therapeutics. They facilitate viral spread, modulate host immune responses, and transfer viral components between cells. Understanding how viruses exploit exosomal pathways is vital for developing antiviral strategies and leveraging exosomes themselves as vehicles for delivering antiviral agents or vaccines [10].

Description

Exosomes are recognized as essential mediators of intercellular communication, playing pivotal roles across a spectrum of biological and pathological processes. Their unique capacity to transport a diverse array of biologically active molecules, including proteins, lipids, and nucleic acids, enables complex cell-to-cell signaling. This fundamental function is particularly evident in cancer, where exosomes emerge as crucial players in diagnosis and therapy [1]. They influence tumor growth, metastasis, and drug resistance within the tumor microenvironment. Understanding these mechanisms is leading to novel diagnostic biomarkers and innovative therapeutic strategies, such as exosome-based drug delivery systems [1]. These systems show immense promise as natural nanocarriers for targeted cancer therapy due to their biocompatibility, low immunogenicity, and ability to cross biological barriers, minimizing off-target effects and enhancing therapeutic efficacy [4]. Exosomes also hold significant promise as potential biomarkers for the early diagnosis and prognosis of digestive system malignancies, where their cargo, reflecting the physiological and pathological state of parental cells, can be non-invasively detected in body fluids [7]. Beyond diagnostics, exosomal components are being explored as novel therapeutic targets, offering a refined approach to cancer treatment [7].

Beyond cancer, exosome-mediated intercellular communication significantly impacts the progression of neurodegenerative diseases, including Alzheimer's and Parkinson's. These vesicles can transfer toxic proteins, microRNAs, and other harmful molecules between neurons and glial cells, directly contributing to disease pathology. Targeting exosome signaling pathways therefore offers potential avenues for therapeutic intervention and the development of diagnostic biomarkers for early detection in these debilitating conditions [2]. Furthermore, exosomes are critical in immune regulation and the pathogenesis of inflammatory diseases. They carry diverse immune modulatory cargos capable of either activating or suppressing immune responses, influencing processes such as antigen presentation, T-cell activation, and cytokine secretion. This broad influence makes them attractive targets for developing new immunotherapies and diagnostics for autoimmune conditions and chronic inflammation [3].

The cardiovascular system also heavily relies on exosomal intercellular communication, contributing to both physiological functions and various pathological conditions. Exosomes facilitate the exchange of genetic material and proteins, thereby influencing vital processes like angiogenesis, cardiac repair, and inflammation in diseases such as myocardial infarction, atherosclerosis, and heart failure. Their potential as reliable biomarkers and novel therapeutic agents in cardiovascular health is actively being explored [5]. Similarly, intercellular communication mediated by exosomes is a key factor in the pathogenesis and progression of several liver diseases, including non-alcoholic fatty liver disease, viral hepatitis, and liver fibrosis. Exosomes transport a diverse array of molecules that modulate inflammation, apoptosis, and fibrogenesis within the liver, making an understanding of these mechanisms crucial for developing new diagnostic tools and targeted therapies [8]. Moreover, exosomes are pivotal players in viral infections. They influence every stage, from pathogenesis to potential therapeutics, by facilitating viral spread, modulating host immune responses, and transferring viral components between cells. Deciphering how viruses exploit exosomal pathways is essential for developing effective antiviral strategies and leveraging exosomes themselves as vehicles for delivering antiviral agents or vaccines [10].

In the context of regenerative medicine, exosomes derived from stem cells have garnered significant attention for their potential in tissue regeneration and stem cell-based therapies. These exosomes carry regenerative molecules that mimic many of the therapeutic effects of their parent cells, actively promoting cell proliferation, differentiation, and tissue repair. This characteristic positions them as a promising cell-free alternative, offering considerable advantages in terms of safety and scalability for regenerative applications [6]. Complementing this, plant-derived exosomes, often referred to as exosome-like nanoparticles, represent an exciting new paradigm for drug delivery. These naturally occurring vesicles exhibit excellent biocompatibility, low toxicity, and high stability. These attributes make them highly suitable for encapsulating and delivering a wide range of therapeutic agents. Their remarkable ability to traverse biological barriers with bioactive compounds offers a promising and sustainable platform for the development of novel biopharmaceuticals [9].

Conclusion

Exosomes are fundamental to cell-to-cell communication across diverse biological systems. They are emerging as crucial players in the diagnosis and therapy of various cancers, driving tumor progression, metastasis, and drug resistance by transporting active molecules within the tumor microenvironment. This makes them pivotal for developing novel diagnostic biomarkers and therapeutic strategies, including advanced drug delivery systems. Beyond oncology, exosome-mediated intercellular communication is a significant factor in neurodegenerative diseases like Alzheimer's and Parkinson's. They transfer toxic proteins and microRNAs between neurons and glial cells, contributing to disease pathology and offering potential avenues for therapeutic intervention and early diagnostic biomarker development. Exosomes also play a critical role in immune regulation and the pathogenesis of inflammatory diseases. They carry diverse immune modulatory cargos that can activate or suppress immune responses, influencing processes like antigen presentation and cytokine secretion. This positions them as attractive targets for new immunotherapies and diagnostics for autoimmune conditions and chronic inflammation. Their influence extends to the cardiovascular system, where they facilitate the exchange of genetic material and proteins, impacting angiogenesis, cardiac repair, and inflammation in conditions such as myocardial infarction and heart failure. Researchers are actively exploring their potential as biomarkers and therapeutic agents in this domain. In the realm of regenerative medicine, stem cell-derived exosomes have garnered attention. These exosomes carry regenerative molecules that mimic the therapeutic effects of their parent cells, promoting cell proliferation and tissue repair. This characteristic positions them as a safer and more scalable cell-free alternative for tissue regeneration. Furthermore, exosomes are promising as potential biomarkers for the early diagnosis and prognosis of digestive system malignancies, detectable non-invasively in body fluids. Their components are also being explored as novel therapeutic targets. Similarly, exosome-mediated communication is a key factor in liver diseases, modulating inflammation, apoptosis, and fibrogenesis, which is crucial for developing new diagnostic tools. Finally, plant-derived exosomes represent a new paradigm for drug delivery due to their biocompatibility, low toxicity, and stability. They can encapsulate and deliver various therapeutic agents across biological barriers. Exosomes are also key players in viral infections, influencing every stage from pathogenesis to potential therapeutics, by facilitating viral spread and modulating host immune responses. Understanding these diverse roles is vital for developing diagnostics and therapies across numerous medical fields.

References

1. Mingxin X, Jinlin L, Bo L (2023) .J Clin Med 12:260.

   , ,

2. Yanan Z, Zhengrong L, Wenxia Y (2022) .Ageing Res Rev 82:101831.

   , ,

3. Xiaoyan H, Jiaxin C, Jinghong L (2024) .Nat Rev Immunol 24:1-18.

   , ,

4. Xuebing L, Xiaomin W, Yang S (2023) .Biomaterials 301:122394.

   , ,

5. Chengyuan L, Junjie X, Yi L (2022) .Basic Res Cardiol 117:63.

   , ,

6. Ying Y, Yan H, Jiaqi X (2023) .J Drug Deliv Sci Technol 88:103758.

   , ,

7. Yuzhen L, Xuejuan F, Yanyan Z (2024) .Int J Mol Sci 25:2106.

   , ,

8. Qiuyuan W, Yunqiang C, Xiaohan J (2021) .J Cell Biochem 122:1344-1355.

   , ,

9. Peng Y, Chenyang Y, Weiwei Z (2020) .J Funct Foods 74:103814.

   , ,

10. Jing Z, Lu W, Mengyang C (2022) .Int Immunopharmacol 110:108427.

    , ,